Form 4: Elanco Director Kirk McDonald Receives Deferred Stock Units
SEC Form 4 Filing
Director Kirk McDonald of Elanco Animal Health Inc. received 18,169 deferred stock units as part of an annual equity award.
Summary
- Kirk McDonald, a director at Elanco Animal Health Inc., received 18,169 deferred stock units.
- These units were granted as part of the annual equity award for non-employee members of the Board of Directors.
- The transaction occurred on November 29, 2024.
- Following this transaction, Mr. McDonald beneficially owns 78,400 shares of Elanco stock.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction of granting stock units to a director, which is a normal part of corporate governance and compensation. There is no indication of any negative or unusual activity.
Positives
- The grant of deferred stock units aligns the interests of the director with the long-term performance of the company.
- The equity award is a standard practice for compensating non-employee board members.
Industry Context
The granting of stock units to board members is a common practice in publicly traded companies to align their interests with shareholders.
Comparison to Industry Standards
- Granting deferred stock units to non-employee directors is a standard practice across many publicly listed companies, including those in the animal health sector.
- Companies like Zoetis and IDEXX Laboratories also use equity-based compensation for their board members.
- The number of units granted is typical for a director's annual equity award, though the specific value depends on the company's stock price and compensation policies.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it aligns the director's interests with the company's performance.
- The grant of stock units does not have a significant impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| May 14, 2024 | Date of the Power of Attorney document. |
| November 29, 2024 | Date of the transaction where deferred stock units were granted. |
| December 03, 2024 | Date the Form 4 was signed. |
Keywords
Elanco Animal Health, Kirk McDonald, deferred stock units, equity award, director, beneficial ownership, Form 4, SEC filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.